Showing results (631-640 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|February 25, 2021
Phenotypic profiling and prognostic significance of immune infiltrates in esophageal squamous cell carcinomaChuqing Pan, Yu Wang, Qianwen Liu, et al.
Oncoimmunology|February 25, 2021
Expand to shield: IL-15 and in situ lymphocytic proliferationGabriela Bindea, Bernhard Mlecnik, Jérôme Galon
Oncoimmunology|December 22, 2016
Know your neighbors: Different tumor microenvironments have implications in immunotherapeutic targeting strategies across MB subgroupsChristina D Pham, Duane A Mitchell
Oncoimmunology|December 22, 2016
Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain gliomaZheng Wang, Chuanbao Zhang, Xing Liu, et al.
Oncoimmunology|December 22, 2016
Immunotherapies targeting CD38 in Multiple MyelomaDjordje Atanackovic, Mary Steinbach, Sabarinath Venniyil Radhakrishnan, et al.
Oncoimmunology|December 22, 2016
From cell biology to immunology: Controlling metastatic progression of cancer via microRNA regulatory networksJae Hyon Park, Evropi Theodoratou, George A Calin, et al.
Oncoimmunology|December 22, 2016
Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cellsJon Amund Kyte, Steinar Aamdal, Svein Dueland, et al.
Oncoimmunology|December 22, 2016
Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumorValentino Le Noci, Michele Sommariva, Monica Tortoreto, et al.
Oncoimmunology|November 18, 2016
Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidineAlena Moudra, Sona Hubackova, Veronika Machalova, et al.
Oncoimmunology|November 18, 2016
Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talkJing Li, Gulidanna Shayan, Lyndsay Avery, et al.
Pageof 379